NDC 0781-3003-70
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0781-3003
- Requested NDC
- 0781-3003-70
- Package NDCs from labels
- 0781-3003-70
- Manufacturer
- National Council for Prescription Drug Programs
- Effective date
- 2012-07-24
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2012-07-24 | Indexing - Billing Unit |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0781-3003-70 | ML - Milliliter | 0781-3003 | c5bea606-8733-403f-9922-27e7cac36f13 | 1 | 2012-07-24 |
| 0781-3003-75 | ML - Milliliter | 0781-3003 | 05b8546b-a7c0-4026-a387-1c23686a3b14 | 1 | 2012-07-24 |
| 0781-3003-92 | ML - Milliliter | 0781-3003 | 733f9055-a903-4ed2-b48c-7d44cb248059 | 1 | 2012-07-24 |
| 0781-3003-95 | ML - Milliliter | 0781-3003 | a6c41535-8339-4e65-88d7-dcfa7adbfaed | 1 | 2012-07-24 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Leuprolide Acetate | LEUPROLIDE ACETATE | Sandoz Inc | 8bd72c1e-2751-4498-a346-bc5e3acbba0b | 2026-05-19 | Warnings, Adverse reactions | Sandoz Inc |
| ZIEXTENZO | PEGFILGRASTIM-BMEZ | Sandoz Inc | 7dada041-6528-4acf-809c-62d271538c9a | 2026-05-14 | Warnings, Adverse reactions | Sandoz Inc |
| fluorometholone | FLUOROMETHOLONE | Sandoz Inc | c9cbf06e-5413-4c3c-9ded-174c856a4ce1 | 2026-05-12 | Warnings, Adverse reactions | Sandoz Inc |
| Sitagliptin Phosphate | SITAGLIPTIN PHOSPHATE | Sandoz Inc | cebc8388-c9db-4e27-8d6b-0d9bdc9d766d | 2026-05-10 | Warnings, Adverse reactions | Sandoz Inc |
| Lisdexamfetamine dimesylate | LISDEXAMFETAMINE DIMESYLATE | Sandoz Inc | 808cce3b-eee8-4f58-8d8a-53a4ce79ae7c | 2026-04-28 | Boxed warning, Warnings, Adverse reactions | Sandoz Inc |
| Pomalidomide | POMALIDOMIDE | Sandoz Inc | 4fcd4978-b2d1-4d1a-b239-717cddb8be1f | 2026-04-15 | Boxed warning, Warnings, Adverse reactions | Sandoz Inc |
| macitentan | MACITENTAN | Sandoz Inc | 91232484-55b7-47dc-bc30-e63a6b469df6 | 2026-04-06 | Boxed warning, Warnings, Adverse reactions | Sandoz Inc |
| Glycopyrrolate | GLYCOPYRROLATE | Sandoz Inc | cb1ae370-ec4f-4114-9860-8f736f72b545 | 2026-04-01 | Warnings, Adverse reactions | Sandoz Inc |
| Brimonidine Tartrate and Timolol Maleate | BRIMONIDINE TARTRATE AND TIMOLOL MALEATE | Sandoz Inc | af21d2e5-0029-4889-ba93-6417baa91ce6 | 2026-03-31 | Warnings, Adverse reactions | Sandoz Inc |
| Voriconazole | VORICONAZOLE | Sandoz Inc | e648a0e4-f324-49dc-a8f6-cf25ff3b2dfe | 2026-03-31 | Warnings, Adverse reactions | Sandoz Inc |
| voriconazole | VORICONAZOLE | Sandoz Inc | e2b3c0b3-02a6-45c3-a8ea-05d210dc9108 | 2026-03-26 | Warnings, Adverse reactions | Sandoz Inc |
| Carbidopa, Levodopa, and Entacapone | CARBIDOPA, LEVODOPA, AND ENTACAPONE | Sandoz Inc | 9c16c0e0-3b97-486b-b7d5-579f5853e2c5 | 2026-03-19 | Warnings, Adverse reactions | Sandoz Inc |
| Estradiol Transdermal System | ESTRADIOL | Sandoz Inc | c714974b-766f-42f2-a846-b0c1f5a60560 | 2026-03-04 | Boxed warning, Warnings, Adverse reactions | Sandoz Inc |
| Drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium | DROSPIRENONE/ETHINYL ESTRADIOL/LEVOMEFOLATE CALCIUM AND LEVOMEFOLATE CALCIUM | Sandoz Inc | 6928f186-190d-4c40-beab-81cf80cd45cb | 2026-03-04 | Boxed warning, Warnings, Adverse reactions | Sandoz Inc |
| Clindamycin in 5 Percent Dextrose | CLINDAMYCIN IN 5 PERCENT DEXTROSE | Sandoz Inc | 231d95a6-5e5f-4a45-a92b-d3d16ef0a7ca | 2026-03-02 | Boxed warning, Warnings, Adverse reactions | Sandoz Inc |
| Olanzapine | OLANZAPINE | Sandoz Inc | c44a96cc-817d-4eb5-a13a-00977f76e666 | 2026-02-26 | Boxed warning, Warnings, Adverse reactions | Sandoz Inc |
| WYOST | DENOSUMAB | Sandoz Inc | 69e4890d-5dd9-42a5-aa41-ce50635eaed7 | 2026-02-20 | Warnings, Adverse reactions | Sandoz Inc |
| Timolol Maleate | TIMOLOL MALEATE | Sandoz Inc | f949fa34-6a9a-40d5-91ab-ff1cbb79b9ea | 2026-02-20 | Warnings, Adverse reactions | Sandoz Inc |
| Olanzapine | OLANZAPINE | Sandoz Inc | 1e9666ef-4271-4834-8496-ccb3125d83db | 2026-02-19 | Boxed warning, Warnings, Adverse reactions | Sandoz Inc |
| Reclast | ZOLEDRONIC ACID | Sandoz Inc | 5a9b3737-9ce6-4a89-b76e-6aab79eba9cf | 2026-02-03 | Warnings, Adverse reactions | Sandoz Inc |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.